AKVION

8-800-200-86-86

AKVION is a pharmaceutical company specializing in unique products for a healthy lifestyle.

We focus on the needs of ordinary people and deal with clinical practices of healthcare professionals.

We develop exclusive formulae, carefully select active ingredients and auxiliary agents and carry out additional research to turn innovative ideas into real-world products.

We have created more than 100 unique and clinically tested pharmaceuticals, which have earned consumer confidence and proved to be popular within the medical community.

We benefit from cooperation with top manufacturers to expand our product portfolio with pharmaceutical drugs produced by our partners and to create comprehensive solutions for doctors and patients.

Our products help keep the reproductive system healthy, sustain users during the cold season and improve their quality of life.

Product quality

The development, production and sale of medical devices, dietary supplements and cosmetics is carried out in accordance with ISO standards 13485: 2016, ISO 9001: 2015, 14001: 2016, 45001: 2018.

All our products are made at the manufacturing facilities that have received the ISO and GMP quality certificates.

PROVEN EFFICIENCY

We carefully monitor all stages of product birth:

We base our formulations on rigorous scientific evidence. The effective action of all active ingredients that we include in our preparations has been proven by reliable research. In addition, we make sure that useful substances are included in the drug in dosages that are required to solve a particular problem.
We select suppliers of all components for our products, giving preference to patented raw materials with proven properties. We pay special attention to the standardization of plant extracts in order to control the exact amount of nutrients. This is the only way to guarantee their beneficial effect.
For the production of our drugs, we conclude contracts with pharmaceutical companies, which comply with GMP standards and have the most modern technological equipment.

As a result, products are born, in the benefits and quality of which we are completely confident.

The effectiveness of this strategy of our company is proved by many factors:

The trust of millions of people who choose our drugs and use them for more than one year. For example, Speroton has been a top male fertility medication for several years, whereas Mense is the best-selling non-hormonal alternative for menopause symptoms. As the marketing data shows, many people learned about our products from relatives and friends, and followed their advice.
Recognition by the medical community. Information about our products is included in their articles, reports, training webinars and lectures by leading experts in the field of pediatrics, reproduction, allergology and others.
The results of clinical trials that are carried out in medical institutions in compliance with all prerequisites.
A bunch of independent professional awards, including the Brand of the Year and Green Cross, plus letters of gratitude and appreciation from organizations, such as the Russian Society of Urology and National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov.

We do not rest on our laurels - our company continues to develop dynamically in all areas: research, production, management, financial.

We bring together the newest scientific discoveries, the results of the latest research, modern standards for pharmaceutical manufacturing and innovative technologies.

HISTORY

The course for innovation was set by the company’s founder and first head – Mikhail Ivanovich Lazarev, an entrepreneur and an inventor.

The molecular encapsulation technology had become the company’s first unique design. Based on that technology, we created Vetoron – a bioavailable form of beta-carotene. It had quickly won favour with professionals and consumers.

At the same time, we were doing a lot of scientific work and were getting ready for a new breakthrough.
It came in the form of a revolutionary vitamin and mineral complex Alfavit which had, for the first time ever, implemented the recommendations of scientists on combined and separate intake of micronutrients.

The next step was studying the properties and features of essential oils, as a result of which a line of Dyshi products appeared for non-drug therapy and prevention of colds.

Drugs for competent support of reproductive health and proper planning of conception became a new niche for the Russian market. We focused on creation of effective and at the same time affordable drugs for increasing male and female fertility. This is how Speroton and Pregnoton appeared, quickly winning the trust of specialists and helping more than one couple to become happy parents.

2002

We launch the Alfavit vitamin and mineral complex (the patent on its composition is held by AKVION) and Qudesan – the first coenzyme Q₁₀ product in Russia intended for cardiology.

2003

AKVION – the exclusive distributor of Olbas Oil in Russia.

2004

We launch the Alfavit Mama’s Health complex, start the Alfavit product line.

2005

The number of ALFAVIT users reaches 5 million people.
Alfavit Kindergarten and Alfavit Schoolchild – the leading brands in the Russian market for goods and services for children.
We launch Focus, an eye care product.

2006

We acquire our own manufacturing facility – the Vneshtorg Farma pharmaceutical plant.
Qudesan and Vetoron are registered as medicinal products.
AKVION is ranked 107th in the ranking of the 250 major advertisers in Russia.

2007

We put a record number of new products on the market.

2008

Qudesan and Vetoron are registered as medicinal products.
We transfer the exclusive rights to the Alfavit, Qudesan, Vetoron, Focus, Quten and Carniton brands to Recordati (Italy).

2009

We launch a unique set of products to prepare men and women for conception – Spematon and Pregnoton.

2010

Qudesan and Vetoron are registered as medicinal products.
New design for the Dyshi series.

2011

We register the enhanced compositions of the Spematon (its name is changed to Speroton) and Pregnoton products.
We implement the Customer Relationship Management (CRM) system.

2012

Dyshi Inhalation Patches is the first medical device produced by AKVION. The Dyshi product line now comprises 10 stock-keeping units (SKU)!
Dyshi Oil Spray marks the beginning of the Dyshi series.
The reproductive-system product line now features the Sinergin antioxidant complex.

2013

Clinical studies of Spematon.
We launch new brands: Vitime Sport, Dietelle, and KidZ.

2014

The reproductive-system product line now features the Sinergin antioxidant complex.
We add gels producing a warming effect for kids and adults to the Dyshi series.

2015

We launch new brands: Vitime Sport, Dietelle, and KidZ.
We launch new products: Pregnoton Mama и Dyshi Oil with a Wristband.
The reproductive-system product line now features the Sinergin antioxidant complex.

2016

The Vitime and Dietelle products are now offered for sale in sports nutrition stores.
We launch new brands: Vitime Sport, Dietelle, and KidZ.
5 new clinical trials were conducted.

2017

A radical redesign of product sites with an emphasis on mobile versions was carried out.
The Vitime and Dietelle products are now offered for sale in sports nutrition stores.

2018

Products are now available on Ozon and Wildberries, the largest online retailers.
7 clinical research studies were held. The overall number of our products clinical research studies has exceeded 50.
A radical redesign of product sites with an emphasis on mobile versions was carried out.

2019

9 unique premium class Akvion products were developed and released.
Products are now available on Ozon and Wildberries, the largest online retailers.
7 clinical research studies were held. The overall number of our products clinical research studies has exceeded 50.

2020

The company’s own online store has started working at akvion.shop. The products are delivered throughout Russia.
The company was certified according to ISO 13485:2016, ISO 9001:2015, 14001:2016 and 45001:2018, which confirm that AKVION’s processes of development, production and sales of medical devices, dietary supplements and cosmetics are fully compliant with international standards.
The online trade channel grows rapidly. The largest marketplaces, SberMarket, Yandex.Market, eApteka and others, joined the list of our partners. The share of online sales in the company’s sales volume reached 1/3.
4 large-scale clinical studies of our own products were performed. Pregnomama (former Pregnoton Mama), Pregnoton, Speroton and Sinergin confirmed their efficiency once more!

2021

The company’s own online store has started working at akvion.shop. The products are delivered throughout Russia.
The company was certified according to ISO 13485:2016, ISO 9001:2015, 14001:2016 and 45001:2018, which confirm that AKVION’s processes of development, production and sales of medical devices, dietary supplements and cosmetics are fully compliant with international standards.
The online trade channel grows rapidly. The largest marketplaces, SberMarket, Yandex.Market, eApteka and others, joined the list of our partners. The share of online sales in the company’s sales volume reached 1/3.
4 large-scale clinical studies of our own products were performed. Pregnomama (former Pregnoton Mama), Pregnoton, Speroton and Sinergin confirmed their efficiency once more!

2022

11 new products under the Akvion brand are launched in the market.
We have built and approved a long-term strategy for developing and promoting the reproductive health products. Our focus is the current needs of doctors (gynecologists and urologists).
We have kicked off the long-term development strategy with significantly more medical sales representatives and creation of a portfolio of medicinal products.
The Mense brand has received media coverage, including the first big advertising campaign on major federal television channels, to reach a much larger target audience and increase the demand for Mense.

2023

The Dyshi line has been complemented with products DysheLORz and Dyshesol, and 5 SKUs have been launched to the market under the company’s own brand.
The company is actively developing the following R&D areas: medicinal products, medical devices, dietary supplements. Contracts for the development and production of medicinal products have been concluded with partners from India and China.
Mense has become the leader in volume sales among non-hormonal oral medicinal products for women during menopause.
Speroton keeps lead in volume sales and monetary value among the medicinal products with L-carnitine for male fertility for the fifth year in a row.
The company has participated in more than 200 events for specialists: doctors, pharmacists, and pharmaceutical industry professionals.